MAB8661
抗-乙型流感病毒抗体，核蛋白，克隆B2、B4混合物
ascites fluid, Chemicon®, from mouse
登录 查看组织和合同定价。
选择尺寸
关于此项目
UNSPSC Code:
12352203
NACRES:
NA.41
eCl@ss:
32160702
Clone:
B2, monoclonal, B4, monoclonal
Species reactivity:
human
Application:
IF
Citations:
11
biological source
mouse
antibody form
ascites fluid
antibody product type
primary antibodies
clone
B2, monoclonal, B4, monoclonal
species reactivity
human
manufacturer/tradename
Chemicon®
technique(s)
immunofluorescence: suitable
isotype
IgG
shipped in
wet ice
Quality Level
Immunogen
流感病毒混合物。
Application
抗乙型流感病毒抗体，核蛋白，克隆B2、B4混合物可检测乙型流感病毒水平，&已发布&验证可用于IF。
研究子类别
传染病 - 病毒
传染病 - 病毒
研究类别
传染病
传染病
间接免疫荧光（1：100）。
最终工作稀释度必须由最终用户确定。
最终工作稀释度必须由最终用户确定。
Biochem/physiol Actions
识别B型流感病毒的所有亚型。识别核蛋白抗原的两个克隆的混合物。
与甲型流感、副流感1、2或3、腺病毒或RSV无交叉反应。
与甲型流感、副流感1、2或3、腺病毒或RSV无交叉反应。
Physical form
未纯化
腹水，0.1%叠氮化钠作为防腐剂。
Preparation Note
自收到之日起在-20°C可稳定保存1年。分装保存以避免反复冻融。为了最大程度地回收产品，需在融化后和取下盖子之前将原始样品管进行离心。
Analysis Note
对照
流感病毒对照玻片，目录号5010-5
流感病毒对照玻片，目录号5010-5
Other Notes
浓度：关于批次特定浓度请参见检验报告。
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
除非我们的目录或产品随附的其他公司文件中另有说明，否则我们的产品预期仅用于研究用途，不得用于任何其他目的，包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或对人类或动物的任何类型的消费或应用。
未找到合适的产品？
试试我们的产品选型工具.
存储类别
12 - Non Combustible Liquids
wgk
nwg
flash_point_f
Not applicable
flash_point_c
Not applicable
Genetic variability of human metapneumovirus isolated from Chilean children, 2003-2004.
Carola Escobar,Vivian Luchsinger,Danielle Bruna de Oliveira,Edison Durigon et al.
Journal of Medical Virology null
Paulina Koszalka et al.
Antiviral research, 164, 91-96 (2019-02-17)
Baloxavir Marboxil (BXM) is an influenza polymerase inhibitor antiviral that binds to the endonuclease region in the PA subunit of influenza A and B viruses. To establish the baseline susceptibility of viruses circulating prior to licensure of BXM and to
Kevin R McCarthy et al.
Proceedings of the National Academy of Sciences of the United States of America, 118(23) (2021-06-03)
Immune memory of a first infection with influenza virus establishes a lasting imprint. Recall of that memory dominates the response to later infections or vaccinations by antigenically drifted strains. Early childhood immunization before infection may leave an imprint with different
Aaron G Schmidt et al.
Cell, 161(5), 1026-1034 (2015-05-12)
Vaccines for rapidly evolving pathogens will confer lasting immunity if they elicit antibodies recognizing conserved epitopes, such as a receptor-binding site (RBS). From characteristics of an influenza-virus RBS-directed antibody, we devised a signature motif to search for similar antibodies. We
Holly C Simmons et al.
PLoS biology, 21(12), e3002415-e3002415 (2023-12-21)
Antibody titers that inhibit the influenza virus hemagglutinin (HA) from engaging its receptor are the accepted correlate of protection from infection. Many potent antibodies with broad, intra-subtype specificity bind HA at the receptor binding site (RBS). One barrier to broad
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持